Accolate and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Accolate (zafirlukast), especially for people who are female, 60+ old, also take Albuterol, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Nosebleed when taking Accolate. It is created by eHealthMe based on reports of 4,145 people who have side effects when taking Accolate from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,073 drugs and 3,094 conditions by eHealthMe. Check the latest studies of Nosebleed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

4,145 people reported to have side effects when taking Accolate.
Among them, 20 people (0.48%) have Nosebleed.

Among these 20 people:

What is the gender of people who have Nosebleed when taking Accolate? *

female: 65 %
male: 35 %

What is the age of people who have Nosebleed when taking Accolate? *

What are other drugs people take besides Accolate? *

What are other side effects people have besides Nosebleed? *

Pneumonia: 8 people, 40.00%
Oedema Peripheral (superficial swelling): 8 people, 40.00%
Sinus Congestion (blockage of sinus): 8 people, 40.00%
Fatigue (feeling of tiredness): 8 people, 40.00%
Weight Decreased: 7 people, 35.00%
Back Pain: 7 people, 35.00%
Chest Pain: 7 people, 35.00%
Colitis (inflammation of colon): 7 people, 35.00%
Confusional State: 7 people, 35.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 7 people, 35.00%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 10.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.00%
Multiple Allergies (allergy to multiple agents): 1 person, 5.00%
Hepatitis C: 1 person, 5.00%
Breast Cancer: 1 person, 5.00%
Blastomycosis (fungal infection caused by fungus blastomyces dermatitidis): 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accolate:

Accolate (4,220 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,073 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,094 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zafirlukast (the active ingredients of Accolate) and Accolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.